Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways

Haematologica. 2017 Aug;102(8):e282-e284. doi: 10.3324/haematol.2017.169128. Epub 2017 May 4.

Jin Han^{1

2

3}, Xu Zhang², Jennifer Oderinde², Santosh L Saraf², Michel Gowhari², Joharah Hassan², Shivi Jain², Victor R Gordeuk², Robert E Molokie^{4

5}

¹ Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, IL, USA remoloki@uic.edu jhan35@uic.edu.
² Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, IL, USA.
³ Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, IL, USA.
⁴ Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, IL, USA remoloki@uic.edu jhan35@uic.edu.
⁵ Jesse Brown VA Medical Center, Chicago, IL, USA.

No abstract available

Publication types